Global Veterinary Sulfa Drugs Market Growth 2025-2031
Description
The global Veterinary Sulfa Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Veterinary sulfa drugs include sulfadiazine (SD), sulfamethazine, sulfamethazine, sulfamethoxazole (SMZ), etc.; sodium sulfamate (SA) and trimethoprim (TMP) act on Intestinal sulfamidine (SG) and peptide sulfothiazole (PST), sulfamethoxypyrazine (SMPZ), sulfadimethoxine (SDM), compound sulfamethoxazole (SMZ+TMP), synergistic sulfonate ( SD+SMZ+TMP), etc. Veterinary sulfa drugs can treat respiratory tract, digestive tract, urinary tract infection; mastitis, metritis and peritonitis in animals.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 147%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Sulfa Drugs Industry Forecast” looks at past sales and reviews total world Veterinary Sulfa Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Sulfa Drugs sales for 2025 through 2031. With Veterinary Sulfa Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Sulfa Drugs industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Sulfa Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Sulfa Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Sulfa Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Sulfa Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Sulfa Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Sulfa Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral Type
Injection Type
Segmentation by Application:
For Swine
For Cattle
For Poultry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MSD Animal Health
Zoetis
Boehringer-Ingelheim
BAYER
Elanco
Merial
Guangdong Dahuanong Animal Health Products
China Animal Husbandry Industry
DBN
Ringpu
Henan Baimu Biotechnology
Huajiu Pharmaceutical
Shangqiu Tianyi Biological Technology
Harbin Lvdasheng Animal Pharmaceutical
BAOLING
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Sulfa Drugs market?
What factors are driving Veterinary Sulfa Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Sulfa Drugs market opportunities vary by end market size?
How does Veterinary Sulfa Drugs break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Veterinary sulfa drugs include sulfadiazine (SD), sulfamethazine, sulfamethazine, sulfamethoxazole (SMZ), etc.; sodium sulfamate (SA) and trimethoprim (TMP) act on Intestinal sulfamidine (SG) and peptide sulfothiazole (PST), sulfamethoxypyrazine (SMPZ), sulfadimethoxine (SDM), compound sulfamethoxazole (SMZ+TMP), synergistic sulfonate ( SD+SMZ+TMP), etc. Veterinary sulfa drugs can treat respiratory tract, digestive tract, urinary tract infection; mastitis, metritis and peritonitis in animals.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 147%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Sulfa Drugs Industry Forecast” looks at past sales and reviews total world Veterinary Sulfa Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Sulfa Drugs sales for 2025 through 2031. With Veterinary Sulfa Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Sulfa Drugs industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Sulfa Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Sulfa Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Sulfa Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Sulfa Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Sulfa Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Sulfa Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral Type
Injection Type
Segmentation by Application:
For Swine
For Cattle
For Poultry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MSD Animal Health
Zoetis
Boehringer-Ingelheim
BAYER
Elanco
Merial
Guangdong Dahuanong Animal Health Products
China Animal Husbandry Industry
DBN
Ringpu
Henan Baimu Biotechnology
Huajiu Pharmaceutical
Shangqiu Tianyi Biological Technology
Harbin Lvdasheng Animal Pharmaceutical
BAOLING
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Sulfa Drugs market?
What factors are driving Veterinary Sulfa Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Sulfa Drugs market opportunities vary by end market size?
How does Veterinary Sulfa Drugs break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
119 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Veterinary Sulfa Drugs by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Veterinary Sulfa Drugs by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
